Drug Therapy for Rheumatoid Arthritis in Adults
Summary of Results: Head-to-Head Comparisons of Oral DMARDs for Rheumatoid Arthritis
Studies of oral disease-modifying anti-rheumatic drugs (DMARDs) include head-to head-comparisons, but the number of studies and patients examined is limited and the strength of evidence in support of the findings is low or moderate. For some outcomes, the evidence is insufficient for a conclusion or the outcomes were not studied.
Keywords: rheumatoid arthritis | RA | DMARDs | disease-modifying | antirheumatic | anti-rheumatic | rheumatic | biologic DMARD | oral DMARD | nonbiologic DMARD | early RA | methotrexate | sulfasalazine | leflunomide | disease activity | symptom response | radiographic progression | functional capacity
- Donahue KE, Jonas D, Hansen RA, et al. Drug Therapy for Rheumatoid Arthritis in Adults: An Update. Comparative Effectiveness Review No. 55 (Prepared by the RTI International–University of North Carolina Evidence-based Practice Center under Contract No. 290-2007-10056-I). Rockville, MD: Agency for Healthcare Research and Quality; April 2012. AHRQ Publication No. 12-EHC025-EF. Available at www.effectivehealthcare.ahrq.gov/dmardsra.cfm.
Your slide tray is being processed.